Chair People
![]() |
Sol J. Barer President & COO, Celgene Corporation |
![]() |
Richard Edlin Principal Shareholder, Greenberg Traurig, LLP |
![]() |
Robert Garnick Senior Vice President, Regulatory, Quality and Compliance, Genentech, Inc. |
![]() |
Les Granow Managing Director, Giuliani Capital Advisors |
![]() |
Barry Greene Chief Operating Officer, Alnylam Pharmaceuticals |
![]() |
Dr. Jeremy M. Levin Global Head of Strategic Alliances, Novartis Institutes for BioMedical Research |
| Tim Opler Managing Director Health Care, Credit Suisse First Boston |
Lewis C. Pell Co-founder and Vice Chairman of the Board, Vision Sciences |
||
![]() |
Jonathan Silverstein General Partner, OrbiMed Advisors, LLC |
Advisory Board
| Shlomo Ben Haim Impulse Dynamics |
Prof Rafael Beyar MD DSc Director, Rambam Medical Center; Dean, Bruce Rappaprot Faculty of Medicine, Technion; Professor, Medicine and Biomedical Engineering |
||
| Dr. Nissim Darvish Partner, Pitango Venture Capital |
Amos Goren Partner, Apax Partners |
||
| Dr. Avraham Ludomirski Founder & Managing Partner, Vitalife Life Sciences Venture Capital |
Participants
![]() |
John
Ashcroft The Ashcroft Group, LLC; Former Attorney General of the United States |
![]() |
Secretary
Tommy Thompson Former Secretary of Health and Human Services, U.S. Department of Health and Human Services |
![]() |
Mark
Auerbach Executive Chairman, Par Pharmaceutical |
![]() |
Sol J. Barer President & COO, Celgene Corporation |
![]() |
Bert E. Brodsky Sandata Technologies Inc. |
![]() |
Richard Edlin Principal Shareholder, Greenberg Traurig, LLP |
![]() |
Stephen Evans-Freke Managing General Partner, Celtic Pharma |
David Fineman President and CEO, KineMed, Inc. |
|
![]() |
Robert Garnick Senior Vice President, Regulatory, Quality and Compliance, Genentech, Inc. |
Robert Glassman Director, Healthcare Investment Banking, Mergers and Acquisitions Group, Merrill Lynch, Inc |
|
| Joseph J. Grano, Jr. Former Chairman & CEO of UBS Paine Webber |
![]() |
Les Granow Managing Director, Giuliani Capital Advisors |
|
![]() |
Barry Greene Chief Operating Officer, Alnylam Pharmaceuticals |
![]() |
Bob Grossman Principal Shareholder and Co-Chair of Israeli Practice Group, Greenberg Traurig, P.A. |
| James Hagale CEO, Bass Pro |
![]() |
Jonathan Javitt Senior Fellow, Potomac Institute for Policy Studies |
|
![]() |
Bruce KenKnight Director of Business Development, Guidant Corporation |
Michael King Senior Biotechnology Analyst, Rodman & Renshaw, LLC |
|
![]() |
Dr. Jeremy M. Levin Global Head of Strategic Alliances, Novartis Institutes for BioMedical Research |
Mario Morino Founder and Chairman, Venture Philanthropy Partners |
|
![]() |
Tim Opler Managing Director Health Care, Credit Suisse First Boston |
Lewis C. Pell Co-founder and Vice Chairman of the Board, Vision Sciences |
|
![]() |
James Rothman Professor, Columbia University College of Physicians & Surgeons; Chief Science Advisor, GE Healthcare |
Ed Rubin Managing Director, Rodman and Renshaw |
|
![]() |
Jonathan Silverstein General Partner, OrbiMed Advisors, LLC |
![]() |
Scott Tarriff President & CEO , Par Pharmaceutical Companies, Inc |
| Michael Vasinkevich Senior Managing Director, Rodman & Renshaw, LLC |
![]() |
Carl Feldbaum Former President - BIO |
Back to Top

























